Avvisto Therapeutics LLC
Type 2 diabetes therapeutics focused on Cycloset
Visit website ContactClaim & upgrade this listingContact details are protected Something wrong? Suggest a correction
Avvisto Therapeutics focuses on Cycloset, an FDA-approved medicine for patients with Type 2 diabetes that acts as a dopamine agonist and insulin sensitizer. The company provides patient information and access to selected publications on the preclinical and clinical research supporting the treatment.
At a Glance
Avvisto Therapeutics LLC is an American manufacturer based in Tiverton, RI.
- Where
- Tiverton, RI
